Carbonyl stress in diabetics with acute coronary syndrome

被引:13
作者
Bora, Sushmita [1 ]
Adole, Prashant Shankarrao [1 ]
机构
[1] Jawaharlal Inst Postgrad Med Educ & Res, Dept Biochem, Pondicherry 605006, India
关键词
GLYCATION END-PRODUCTS; TRIOSEPHOSPHATE ISOMERASE DEFICIENCY; OXIDATIVE STRESS; INSULIN-RESISTANCE; GLYOXALASE-I; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; CARDIOVASCULAR-DISEASE; ADVANCED GLYCOXIDATION; FOLLOW-UP; METHYLGLYOXAL;
D O I
10.1016/j.cca.2021.06.002
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The prevalence and incidence of diabetes mellitus (DM) are increasing worldwide bringing with it a significantly higher rate of complications. Various mechanisms such as carbonyl stress, polyol pathway, oxidative stress, hexosamine pathways, diacylglycerol/protein kinase-C activation, etc., are responsible for the pathogenesis of DM and its complications. Persistent hyperglycaemia and inhibition of metabolising and detoxifying enzymes lead to the excessive synthesis of carbonyl compounds such as methylglyoxal, glyoxal, and 3-deoxyglucosone, resulting in carbonyl stress. The substrates, metabolizing and detoxifying enzymes of carbonyl compounds are discussed. The mechanistic roles of carbonyl compounds and advanced glycation end products (AGEs) in atherosclerosis, insulin resistance, thrombogenicity, and endothelial dysfunction in animal and cell culture model of DM and patients with DM are summarised. Because of the essential role of carbonyl stress, therapeutics are aimed at scavenging, metabolizing, detoxifying, and inhibiting carbonyl compounds or AGEs so that their harmful effects are minimized. Clinically used drugs, plants extracts and miscellaneous chemical with antiglycation properties are used in an animal model of DM to alleviates the impact of carbonyl compounds. Extensive clinical trials with derivatisation of available antiglycation agents to increase the bioavailability and decrease side effects are warranted further.
引用
收藏
页码:78 / 86
页数:9
相关论文
共 130 条
[1]   Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects [J].
Al-Hamodi, Zaid ;
Ismail, Ikram S. ;
Saif-Ali, Riyadh ;
Ahmed, Khaled A. ;
Muniandy, Sekaran .
CARDIOVASCULAR DIABETOLOGY, 2011, 10
[2]   Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products [J].
Aldini, Giancarlo ;
Vistoli, Giulio ;
Stefek, Milan ;
Chondrogianni, N. ;
Grune, Tilman ;
Sereikaite, Jolanta ;
Sadowska-Bartosz, Izabela ;
Bartosz, Grzegorz .
FREE RADICAL RESEARCH, 2013, 47 :93-137
[3]   Incidence of Diabetes and Prediabetes and Predictors of Progression Among Asian Indians: 10-Year Follow-up of the Chennai Urban Rural Epidemiology Study (CURES) [J].
Anjana, Ranjit Mohan ;
Rani, Coimbatore Subramanian Shanthi ;
Deepa, Mohan ;
Pradeepa, Rajendra ;
Sudha, Vasudevan ;
Nair, Haridas Divya ;
Lakshmipriya, Nagarajan ;
Subhashini, Sivasankaran ;
Binu, Valsalakumari Sreekumarannair ;
Unnikrishnan, Ranjit ;
Mohan, Viswanathan .
DIABETES CARE, 2015, 38 (08) :1441-1448
[4]  
[Anonymous], 2019, IDF Diabetes Atlas, V9th
[5]  
Battula S, 2019, J Clin Res, V8, P67
[6]   Glyceraldehyde-3-phosphate dehydrogenase activity as an independent modifier of methylglyoxal levels in diabetes [J].
Beisswenger, PJ ;
Howell, SK ;
Smith, K ;
Szwergold, BS .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2003, 1637 (01) :98-106
[7]  
Bindal S., 2018, J NEURO RES, V8, P4
[8]   Serum paraoxonase is reduced in type 1 diabetic patients compared to non-diabetic, first degree relatives; influence on the ability of HDL to protect LDL from oxidation [J].
Boemi, M ;
Leviev, I ;
Sirolla, C ;
Pieri, C ;
Marra, M ;
James, RW .
ATHEROSCLEROSIS, 2001, 155 (01) :229-235
[9]   Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective [J].
Bongarzone, Salvatore ;
Savickas, Vilius ;
Luzi, Federico ;
Gee, Antony D. .
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (17) :7213-7232
[10]   Association between carbonyl stress markers and the risk of acute coronary syndrome in patients with type 2 diabetes mellitus-A pilot study [J].
Bora, Sushmita ;
Adole, Prashant S. ;
Motupalli, Nissy ;
Pandit, Vinay R. ;
Vinod, Kolar V. .
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (06) :1751-1755